Peter Behner - 01 Sep 2026 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Reporting relationship: Director
Issuer ticker: INKT
Reported as of: 01 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Sep 2026, 10:20:55 UTC
Prior SEC filing: 02 Jun 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Melissa Orilall, Attorney-in-Fact

Key filing fact

Peter Behner filed Form 4 for MiNK Therapeutics, Inc. (INKT) on 02 Sep 2026.

Key facts

This page summarizes Peter Behner's Form 4 filing for MiNK Therapeutics, Inc. (INKT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Sep 2026, 10:20.

Change

Previous filing in this sequence was filed on 02 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001851420 Primary reporting owner

Behner Peter

Relationship: Director
Address: 149 FIFTH AVENUE, SUITE 500, NEW YORK
Signature: By: /s/ Melissa Orilall, Attorney-in-Fact
Signature date: 01 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INKT transaction

Common Stock

Award

Transaction value
Shares: +1,485
Change %: +6.5%
Price: $10.95^*
Shares after: 24,404
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.